It is well accepted that the C cells of the thyroid contain somatostatin, but the role in local endocrine function has not yet been firmly established in this organ, and it has not been proved that thyroidal somatostatin is released into the circulation. We have measured the contents of somatostatin-like immunoreactivity in the effluent of canine thyroid glands perfused without recirculation with a synthetic buffer medium. During basal conditions a definite release was consistently found in the order of 10 pg/ml corresponding to 12 pg/min. The somatostatin-like immunoreactivity was studied in dilution experiments and by gelfiltration chromatography, and found to have properties identical to those of synthetic cyclic somatostatin, which was also recovered quantitatively when added to sampling tubes. Various compounds were infused in concentrations that are highly active in pancreas perfusion experiments. 14-min infusion of arginine, 5 and 11.5 mmol/liter; isoproterenol, 10 and 23.7 nmol/liter and 68.7 mumol/liter; acetylcholine, 5 mumol/liter, carbamylcholine, 10 and 100 mumol/liter; glucagon, 1 and 30 nmol/liter; and porcine calcitonin, 1 and 100 ng/ml did not affect the basal release of somatostatin-like immunoreactivity significantly. Neither did an increase from the control level of 4 mmol/liter glucose of 10 or 20 mmol/liter, nor an increase in the control level of 4.4 mmol/liter K+ to 7.5 or 14.4 mmol/liter. Each of these compounds were tested in three […] We have measured the contents of somatostatin-like immunoreactivity in the effluent of canine thyroid glands perfused without recirculation with a synthetic buffer medium. During basal conditions a definite release was consistently found in the order of 10 pg/ml corresponding to 12 pg/min. The somatostatin-like immunoreactivity was studied in dilution experiments and by gel-filtration chromatography, and found to have properties identical to those of synthetic cyclic somatostatin, which was also recovered quantitatively when added to sampling tubes.
A B S T R A C T It is well accepted that the C cells of the thyroid contain somatostatin, but the role in local endocrine function has not yet been firmly established in this organ, and it has not been proved that thyroidal somatostatin is released into the circulation.
We have measured the contents of somatostatin-like immunoreactivity in the effluent of canine thyroid glands perfused without recirculation with a synthetic buffer medium. During basal conditions a definite release was consistently found in the order of 10 pg/ml corresponding to 12 pg/min. The somatostatin-like immunoreactivity was studied in dilution experiments and by gel-filtration chromatography, and found to have properties identical to those of synthetic cyclic somatostatin, which was also recovered quantitatively when added to sampling tubes.
Various compounds were infused in concentrations that are highly active in pancreas perfusion experiments. 14-min infusion of arginine, 5 and 11.5 mmol/ liter; isoproterenol, 10 and 23.7 nmol/liter and 68.7 gmol/liter; acetylcholine, 5 ,umol/liter, carbamylcholine, 10 and 100 gmol/liter; glucagon, 1 and 30 nmol/ liter; and porcine calcitonin, 1 and 100 ng/ml did not affect the basal release of somatostatin-like immunoreactivity significantly. Neither did an increase from the control level of 4 mmol/liter glucose of 10 or 20 mmol/liter, nor an increase in the control level of 4.4 mmol/liter K+ to 7.5 or 14.4 mmol/liter. Each of these compounds were tested in three or four dogs.
The effect of an increase in Ca++ from the control level of 1.5 (6) (7) (8) , and in vivo and in vitro studies have demonstrated that the somatostatin is released in response to various physiological and pharmacological stimuli (9) (10) (11) (12) . These findings have contributed to the idea that somatostatin acts as a physiological paracrine mediator.
iodothyronine release have been conflicting (13) (14) (15) (16) , and we found no such action in the perfused canine thyroid (17) . The evidence for an interrelationship with calcitonin release has also been controversial (18) (19) (20) (21) (22) (23) (24) (25) (26) . These previous investigations have all been directed at studying an effect of administered somatostatin on the thyroid. In the present study we have approached the question in another way, namely by measuring release of somatostatin-like immunoreactivity (SLI)l from the thyroid and trying to induce changes in the secretion.
METHODS
Thyroid perfusion was performed in mongrel dogs weighing [18] [19] [20] [21] [22] [23] [24] [25] [26] kg. In the dog, the two thyroid lobes are separate and can be perfused simultaneously and independently. The technique has been described in detail elsewhere (27, 28) . In brief, the thyroid lobes were isolated in situ so that perfusion medium pumped into a segment of each common carotic artery could be collected quantitatively from each lobe through catheters in the internal jugular veins. The dog was exsanguinated after the insertion of the afferent catheters. Once-through perfusions were performed with a KrebsRinger bicarbonate buffer modified to the ion concentrations of dog plasma: Na+ 140.0; K+ 4.4; Ca'+ 1.5; Mg++ 0.5; C1-121.9; SO4--0.5; H2P04-1.1; I-3.67 x 10-4; and HCO3- 24.4 mmol/liter, with the addition of bovine serum albumin 0.2%, dextran 4% (70,000 M, Pharmacia Fine Chemicals, Uppsala, Sweden) and glucose 4.0 mmol/liter. The flow rate for each lobe was 0.63 ml/min (0.5-1.0 ml/g tissue per min). Perfusion pressure was constant at 30-40 mm Hg. The effluents from 2-min intervals were collected in polyethylene tubes containing 200 ,ul 30% neutral EDTA.
The compounds to be tested were pumped into the medium through a cannula penetrating a rubber membrane on the afferent catheter at a rate of 6.3 ,ul/min giving the final concentations indicated in Table I . Mixing was achieved in a small volume drop-chamber introduced between the thyroid lobes and the rubber membrane (17) . SLI was measured by radioimmunoassay using wick chromatography for separation of free and antibody-bound somatostatin (29) . 200 ,l standard made up in perfusion medium including EDTA or 200 ,ul sample, and 50 ,ul somatostatin antibody 1:10,000 were incubated for 24 h, then 50 IlI 125I-tyrosinel'-somatostatin was added and further incubated for 24 h at 4°C. The detection limit was 2-4 pg/ml, depending on the age of the tracer. The interassay coefficient of variation was 7.4%.
The stability of somatostatin in thyroid effluent and the recovery throughout the period from collection of samples including the radioimmunoassay incubations were tested by adding known amounts (100 pg/ml final concentration) of crystalline somatostatin to every other of a series of sampling tubes receiving effluent during basal conditions in two perfusion experiments. The recovery was 101.7±+5.6% (mean+±SD,
The SLI in the thyroid effluent was studied by dilution experiments, which gave variations in binding percentages parallel to that of standards ( Fig. 1 ). In addition, effluent samples obtained just after start of Ca++ infusion, i.e., with 1Abbreviations used in this paper: DB-cAMP, N6, 02_ dibutyryl cyclic adenosine monophosphate; SLI, somatostatin-like immunoreactivity.
very high SLI contents were chromatographed on G-25 Sephadex (fine) columns. The chromatographical properties were identical to those of synthetic cyclic somatostatin (Fig.  2) , which is eluted shortly after the total volume ofthe column. Synthetic somatostatin and SLI was thus adsorbed identically onto Sephadex. The adsorption was much less pronounced than for iodinated tyrosinell-somatostatin (10) . 10 ,ug/ml of triiodothyronine, thyroxine, reverse triiodothyronine, mono-and diiodotyrosin and thyroglobulin, and 30 ,ug/ml of porcine and salmon calcitonin, and 30 ,ug/ml cAMP did not interfere in the somatostatin radioimmunoassay. L 
RESULTS
The influence of various concentrations of glucose, arginine, isoproterenol, acetylcholine, carbamylcholine, glucagon, porcine calcitonin, potassium, and calcium on basal SLI release from perfused thyroid lobes was tested by infusing the compounds for 14 min with control intervals of 18 min. The effect of the different calcium concentrations was tested in random order in the same thyroid lobe in five dogs, whereas the other substances were infused in three or four thyroids. Each substance was only tested in one lobe from each dog. In the individual perfusion experiments these compounds were also infused in alternating order, to avoid any possible long acting influence of the preceding exposure to another compound or to a different concentration of the same compound.
During the control periods the basal SLI concentration in the effluent was -10 pg/ml (Table I ). The only compound that exerted any effect on somatostatin release was calcium. 1 mmol/liter DB-cAMP was also infused in three thyroids. The interpretation of the release pattern was somewhat hampered because this compound interferes in the radioimmunoassay, resulting in a spurious elevation in SLI. In these experiments the average apparent SLI value in effluent increased from 14 .2±+1.9 to 67.0±+1.7 pg/ml (±SE). However, similar SLI readings were obtained when 1 mmol/ liter DB-cAMP in perfusion medium was added directly in the radioimmunoassay, suggesting that SLI secretion was unaffected. The impression that the apparent effect of DB-cAMP was due solely to assay interference is further supported by the identical SLI readings in the three experiments contrasting the highly variable responses to calcium (Table I) In most experiments the calcium indu sponses were higher initially than later on stimulation. In Fig. 4 , which illustrates th Ca++ infusion of a sufficient duration t( release dynamics, this pattern is clearly de In other words, the response of the SLI se in the thyroid is "biphasic" as it is fo D cells (10) .
To further study a possible effect of c; SLI release, salmon and porcine calcitonin during calcium stimulation. Fig. 4 illustrat4 two experiments in which 10 ng/ml and 1 ,u calcitonin and 1 ,ug/ml porcine calcitonin di the submaximally stimulated SLI release. The present study demonstrates that thyroidal SLI is mobilizable and may be released into the circulation. The SLI containing cells in the thyroid seems to be perculiarly insensitive to stimulation with compounds and nutrients, which are powerful SLI secretagogues elsewhere (10, 29) . Increases in perfusate calcium, however, induce a pronounced release of SLI from the thyroid gland as is the case in the pancreas (10) .
Somatostatin has been found in many different organs and tissues including the hypothalamus, pancreas, and intestine (30) , where pronounced inhibitory effects on hormonal release, probably physiologically significant, have been demonstrable (30) . In the thyroid gland, immunoreactive somatostatin has been found 25I-tyrosinell-in several species (1-3, 5), including dogs (4) . Im-*) and by an munohistological studies have shown that it is situated :2, 1:4, 1:8, in the C cells, and it has been suggested that SLI is localized in cells also containing calcitonin (3, 31 (20, 22, 25) , whereas some have not been able to disclose any such action (18, 21, 23, 24) .
CRYSTALLINE
In the present study we have demonstrated an unequivocal, but relatively low basal SLI release of -12 pg/min from the two perfused thyroid lobes. This rate of release is low compared with that from e.g., the 50 60ml pancreas (9, 10) and the stomach (11, 12) and it is unlikely that thyroidal SLI contributes significantly to the tatin immuno-circulating SLI, which in the normal dog is 100-150 matostatin and pg/ml (32) . However, the very dispercity of SLI cells 1 ml and total in the thyroid suggests that although the venous con- in common C cells, also favors the idea of a "paracrine" system.
The concept of a mutual dependence between the two hormones was recently supported by the report of Chiba et al. (33) demonstrating a stimulatory effect of (Asu1'7)-eel calcitonin on somatostatin release from the isolated perfused rat stomach (33) . However, even high concentrations of salmon and porcine calcitonin had no effect on basal or submaximally stimulated thyroidal SLI release in the present study. The discrepancy may So are periods of infusion of salmon calcitonin (S-CT) 10 ng/ml and 1 gg/ml and porcine calcitonin (P-CT) 1 ug/ml. 
